Anti-inflammatory properties of the protein kinase C inhibitor, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model-Reference-Cited by-同舟云学术

Anti-inflammatory properties of the protein kinase C inhibitor, 3-[1-[3-(dimethylamino)propyl]-1H-indol-3-yl]-4(1H-indol-3-yl)-1H-pyrrole-2,5-dione monohydrochloride (GF109203X) in the PMA-mouse ear edema model

Published:1993-03 Issue:S1 Volume:39 Page:C169-C173
ISSN:0065-4299
Container-title:Agents and Actions
language:en
Short-container-title:Agents and Actions

Author:

Kuchera S.,Barth H.,Jacobson P.,Metz A.,Schaechtele C.,Schrier D.

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical),Toxicology,Pharmacology,Immunology

Link

http://link.springer.com/content/pdf/10.1007/BF01972756.pdf

Reference8 articles.

1. Y. Nishizuka,Studies and prospectives of the protein kinase family for cellular regulation. Cancer63, 1892–1903 (1989).

2. J. M. Young, B. M. Wagner and D. A. Spires,Tachyphylaxis in 12-O-tetradecanoylphorbolacetate- and arachidonic acid-induced ear edema. J. Invest. Dermatol.80, 48–52 (1983).

3. C. R. Loomis and R. M. Bell,Sangivamycin, a nucleoside analogue, is a potent inhibitor of protein kinase C. J. Biol. Chem.263, 1682–1692 (1988).

4. H. Hidaka, M. Inagaki, S. Kawamoto and I. Sasaki,Isoquinolinesulfonamides, novel and potent inhibitor of cyclic nucleotide-dependent protein kinase and protein kinase C. Biochemistry23, 5036–5041 (1984).

5. T. Tamaoki, H. Nomoto, I. Takahashi, Y. Kato, M. Morimoto and F. Tomita,Staurosporine, a potent inhibitor of phospholipid/Ca ++ dependent protein kinase. Biochem. Biophys. Res. Commun.135, 397–402 (1986).

Cited by 30 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A versatile imaging platform with fluorescence and CT imaging capabilities that detects myeloperoxidase activity and inflammation at different scales;Theranostics;2019

2. ROS scavenging Mn3O4nanozymes forin vivoanti-inflammation;Chemical Science;2018

3. Treatment of Skin Inflammation with Benzoxaborole Phosphodiesterase Inhibitors: Selectivity, Cellular Activity, and Effect on Cytokines Associated with Skin Inflammation and Skin Architecture Changes;Journal of Pharmacology and Experimental Therapeutics;2016-06-27

4. Vasoactive intestinal peptide prevents PKCε-induced intestinal epithelial barrier disruption during EPEC infection;American Journal of Physiology-Gastrointestinal and Liver Physiology;2015-03-01

5. Inhibition of Toll-Like Receptor-Mediated Inflammation In Vitro and In Vivo by a Novel Benzoxaborole;Journal of Pharmacology and Experimental Therapeutics;2012-11-28